Orotic aciduria type 1
Other Names for this Disease
- Orotidylic pyrophosphorylase and orotidylic decarboxylase deficiency
- UMPS deficiency
- Uridine monophosphate synthase deficiency
- UMP synthtase deficiency
- Orotate phosphoribosyltransferase and omp decarboxylase deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Orotic aciduria type I is treated by taking supplements of the compound uridine. Affected individuals who take uridine show significant improvement in symptoms.
Last updated: 4/2/2012
- Nyhan WL. Disorders of purine and pyrimidine metabolism. Molecular Genetics and Metabolism. 2005; 86:25-33. http://www.ncbi.nlm.nih.gov/pubmed/16176880. Accessed 4/2/2012.
|Generic Name||Uridine triacetate|
(Wellstat Therapeutics, Inc.)
The FDA has approved this product to be used in this manner.
|Treatment of hereditary orotic aciduria.|
|More Information about this product||Drug Information Portal|